Mini-Reviews in Medicinal Chemistry · 2023 · 15 citations · 61 references
MedicineMolecular BiologyMolecular GeneticsDiabetologyMetabolic RegulationMolecular PhysiologyDiabetes MellitusDiabetes Mellitus BiochemistryGlucose HomeostasisGlycemic ControlInsulin ResistanceDiabetes Mellitus MetabolismDiabetes Mellitus PathophysiologyGlucose Homeostasis DisruptionGlucose Homeostasis DisturbanceGlucose Metabolism DisordersHepatic Glucose ProductionMetabolic TherapiesType 2 Diabetes Biochemistry
The glucokinase regulator (GCKR) gene encodes an inhibitor of the glucokinase enzyme (GCK), found only in hepatocytes and responsible for glucose metabolism. A common GCKR coding variation has been linked to various metabolic traits in genome-wide association studies. Rare GCKR polymorphisms influence GKRP activity, expression, and localization. Despite not being the cause, these variations are linked to hypertriglyceridemia. Because of their crystal structures, we now better understand the molecular interactions between GKRP and the GCK. Finally, small molecules that specifically bind to GKRP and decrease blood sugar levels in diabetic models have been identified. GCKR allelic spectrum changes affect lipid and glucose homeostasis. GKRP dysfunction has been linked to a variety of molecular causes, according to functional analysis. Numerous studies have shown that GKRP dysfunction is not the only cause of hypertriglyceridemia, implying that type 2 diabetes could be treated by activating liver-specific GCK via small molecule GKRP inhibition. The review emphasizes current discoveries concerning the characteristic roles of glucokinase and GKRP in hepatic glucose metabolism and diabetes. This information has influenced the growth of directed molecular therapies for diabetes, which has improved our understanding of lipid and glucose physiology.
61
Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001
Ali H. Mokdad, Earl S. Ford, Barbara A. Bowman et al. · JAMA · 2003 · 5.9K citations
Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels
Richa Saxena, Benjamin F. Voight, Valeriya Lyssenko et al. · Science · 2007 · 2.9K citations
Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy
Joseph Grimsby, Ramakanth Sarabu, Wendy L. Corbett et al. · Science · 2003 · 537 citations
Nicola L. Beer, Nicholas D. Tribble, Laura McCulloch et al. · Human Molecular Genetics · 2009 · 398 citations · Full text